Roche to Help Simulations Plus Develop Drug Interaction Software | GenomeWeb
NEW YORK (GenomeWeb News) – Simulations Plus said today that it has signed a multi-year collaboration pact with Hoffmann La Roche, under which the pharmaceutical firm will provide funding and feedback in developing the firm’s GastroPlus software program for drug-drug interaction studies.
Lancaster, Calif.-based Simulations Plus said Roche would provide funding for the equivalent of one full-time scientist for two years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.